Copper inhibits ATR and synergizes with PARP inhibitors (RNA-seq)
This study unveils copper targeting ATR signaling, synergizing with PARPi to suppress ovarian cancer. Overall design: RNA-seq of ES-2 derived drug-adaptive cells and parental cells